PSMA anticorps (C-Term)
Aperçu rapide pour PSMA anticorps (C-Term) (ABIN2470727)
Antigène
Voir toutes PSMA (FOLH1) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Purification
- Immunoaffinity Chromatography
-
Immunogène
- FOLH1 antibody was raised against amino acids from the C-Terminus of FOLH1 (Human).
-
-
-
-
Indications d'application
- FOLH1 antibody can be used in ELISA, Western Blot, immunohistochemistry starting at 10 μg/mL, and immunoprecipitation
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 10 mM PBS, pH 7.4, BSA, sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- As with all antibodies avoid freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store FOLH1 antibody at 4 °C or -20 °C.
-
-
- PSMA (FOLH1) (Folate Hydrolase (Prostate-Specific Membrane Antigen) 1 (FOLH1))
-
Autre désignation
- FOLH1
-
Sujet
- PMSA (FOLH1) is a type II transmembrane glycoprotein belonging to the M28 peptidase family. Three functionally distinct proteins are encoded, including poly-gamma-glutamate carboxypeptidase in the intestine, N-acetylated alpha-linked acidic dipeptidase 1 in the brain, and prostate- specific membrane antigen in the prostate. A mutation in the intestinal form may be associated with impaired intestinal absorption of dietary folates, resulting in low blood folate levels and consequent hyperhomocysteinemia. The form expressed in the brain may be involved in a number of pathological conditions associated with glutamate excitotoxicity. The prostate form is up-regulated in cancerous cells and is used as an effective diagnostic and prognostic indicator of prostate cancer. This gene likely arose from a duplication event of a nearby chromosomal region.
-
ID gène
- 2346
-
UniProt
- Q04609
Antigène
-